G. Breccia: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Characterization of inducible cold-active β-glucosidases from the psychrotolerant bacterium Shewanella sp. G5 isolated from a sub-Antarctic ecosystem

Héctor A. Cristóbal, André Schmidt, Erika Kothe, Javier Breccia, Carlos M. Abate

Journal:

Enzyme and Microbial Technology

Year:

2009

Language:

english

File:

PDF, 710 KB

english, 2009

52

Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution

Massimo Breccia, Franco Mandelli, Maria C. Petti, Mariella D’Andrea, Edoardo Pescarmona, Stefano A. Pileri, Ida Carmosino, Eleonora Russo, Paolo De Fabritiis, Giuliana Alimena

Journal:

Leukemia Research

Year:

2004

Language:

english

File:

PDF, 68 KB

english, 2004

53

Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformation

Massimo Breccia, Marco Mancini, Mauro Nanni, Gianna Maria D’Elia, Ida Carmosino, Roberto Latagliata, Chiara Sarlo, Franco Mandelli, Giuliana Alimena

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 85 KB

english, 2005

54

Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment

Latagliata Roberto, Breccia Massimo, Carmosino Ida, Sarlo Chiara, Montefusco Enrico, Mancini Marco, Chistolini Antonio, De Cuia Rosa, Russo Eleonora, Morano Salvatore Giacomo, Biondo Francesca, Spadea

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 98 KB

english, 2005

55

Myelodysplastic syndromes in patients under 50 years old: a single institution experience

Massimo Breccia, Andrea Mengarelli, Marco Mancini, Francesca Biondo, Fabiana Gentilini, Roberto Latagliata, Franco Mandelli, Giuliana Alimena

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 74 KB

english, 2005

56

Erratum to “Elderly patients with PH+ chronic myelogenous leukemia (CML): Results of imatinib mesylate treatment” [Leuk. Res. 29 (2005) 287–291]

Roberto Latagliata, Massimo Breccia, Ida Carmosino, Chiara Sarlo, Enrico Montefusco, Marco Mancini, Fiammetta Natalino, Antonio Chistolini, Rosa De Cuia, Eleonora Russo, Giacomo Salvatore Morano, Fran

Journal:

Leukemia Research

Year:

2005

File:

PDF, 32 KB

2005

57

Usefulness and prognostic impact on survival of WHO reclassification in FAB low risk myelodyplastic syndromes

Massimo Breccia, Ida Carmosino, Francesca Biondo, Marco Mancini, Eleonora Russo, Roberto Latagliata, Giuliana Alimena

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 89 KB

english, 2006

58

Discontinuation of imatinib therapy after achievement of complete molecular response in a Ph+ CML patient treated while in long lasting complete cytogenetic remission (CCR) induced by interferon

M. Breccia, D. Diverio, F. Pane, M. Nanni, E. Russo, F. Biondo, A. Frustaci, F. Gentilini, G. Alimena

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 100 KB

english, 2006

59

Impaired fasting glucose level as metabolic side effect of nilotinib in non-diabetic chronic myeloid leukemia patients resistant to imatinib

M. Breccia, M. Muscaritoli, F. Gentilini, R. Latagliata, I. Carmosino, F. Rossi Fanelli, G. Alimena

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 239 KB

english, 2007

60

Isolated thrombocytosis as first sign of chronic myeloid leukemia with e6a2 BCR/ABL fusion transcript, JAK2 negativity and complete response to imatinib

Massimo Breccia, Laura Cannella, Daniela Diverio, Paola Streponi, Mauro Nanni, Caterina Stefanizzi, Fiammetta Natalino, Sergio Mecarocci, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 91 KB

english, 2008

61

Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate

Giuliana Alimena, Massimo Breccia, Luigia Luciano, Fabrizio Quarantelli, Daniela Diverio, Barbara Izzo, Biagio De Angelis, Marco Mancini, Roberto Latagliata, Ida Carmosino, Mauro Nanni, Marco Picardi,

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 205 KB

english, 2008

62

Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorized as unclassified (MDS/MPD-U) by WHO classification

Laura Cannella, Massimo Breccia, Roberto Latagliata, Annamaria Frustaci, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 80 KB

english, 2008

63

Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma

Massimo Breccia, Maurizio Martelli, Laura Cannella, Eleonora Russo, Erica Finolezzi, Caterina Stefanizzi, Anna Levi, Annamaria Frustaci, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 80 KB

english, 2008

64

Male patients with chronic myeloid leukemia treated with imatinib involved in healthy pregnancies: Report of five cases

Massimo Breccia, Laura Cannella, Enrico Montefusco, Annamaria Frustaci, Matteo Pacilli, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 67 KB

english, 2008

65

Cardiac events in imatinib mesylate-treated chronic myeloid leukemia patients: A single institution experience

Massimo Breccia, Laura Cannella, Annamaria Frustaci, Caterina Stefanizzi, Anna Levi, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 122 KB

english, 2008

66

Ocular side effects in chronic myeloid leukemia patients treated with imatinib

Massimo Breccia, Fabiana Gentilini, Laura Cannella, Roberto Latagliata, Ida Carmosino, Annamaria Frustaci, Giuliana Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 79 KB

english, 2008

67

Fasting glucose improvement under dasatinib treatment in an accelerated phase chronic myeloid leukemia patient unresponsive to imatinib and nilotinib

M. Breccia, M. Muscaritoli, L. Cannella, C. Stefanizzi, A. Frustaci, G. Alimena

Journal:

Leukemia Research

Year:

2008

Language:

english

File:

PDF, 75 KB

english, 2008

68

Occurrence of colon adenocarcinoma in chronic myeloid leukemia patients treated with imatinib: Report of two cases and review of the literature

A. Frustaci, M. Breccia, L. Cannella, C. Stefanizzi, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 74 KB

english, 2009

69

Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal

M. Breccia, R. Latagliata, L. Cannella, I. Carmosino, R. De Cuia, A. Frustaci, C. Stefanizzi, M. Santopietro, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 88 KB

english, 2009

70

WPSS versus simplified myelodysplastic syndrome risk score: Which is the best tool for prediction of survival in myelodysplastic patients?

Massimo Breccia, Laura Cannella, Caterina Stefanizzi, Roberto Latagliata, Angelo Fama, Michelina Santopietro, Giuliana Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 85 KB

english, 2009

71

Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual disease

Massimo Breccia, Laura Cannella, Caterina Stefanizzi, Michelina Santopietro, Rosa De Cuia, Daniela Diverio, Giuliana Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 109 KB

english, 2009

72

The metabolic consequences of imatinib mesylate: Changes on glucose, lypidic and bone metabolism

Massimo Breccia, Giuliana Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 128 KB

english, 2009

73

Dasatinib in the management of lymphoid blast crisis of Philadelphia-positive chronic myeloid leukemia with multiple extra-medullary and intracranial localizations

Giuliana Alimena, Massimo Breccia, Roberto Latagliata, Sara Grammatico, Angela Matturro, Saveria Capria, Maria Stefania De Propris, Daniela Diverio, Giovanna Meloni

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 1.29 MB

english, 2009

74

Second-generation tyrosine kinase inhibitors before allogeneic stem cell transplantation in patients with chronic myeloid leukemia resistant to imatinib

Massimo Breccia, Francesca Palandri, Anna Paola Iori, Elisabetta Colaci, Roberto Latagliata, Fausto Castagnetti, Giovanni Fernando Torelli, Sara Usai, Veronica Valle, Giovanni Martinelli, Gianantonio

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 130 KB

english, 2010

75

Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?

Massimo Breccia, Giuliana Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 91 KB

english, 2009

76

Nilotinib: A second-generation tyrosine kinase inhibitor for chronic myeloid leukemia

Massimo Breccia, Giuliana Alimena

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 150 KB

english, 2010

77

Modifications of fasting glucose values as first sign of resistance in chronic myeloid leukemia chronic phase patients during imatinib treatment

Massimo Breccia, Maurizio Muscaritoli, Laura Cannella, Giuseppina Loglisci, Michelina Santopietro, Giuliana Alimena

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 293 KB

english, 2010

78

From FAB to 2008 WHO classification: The wide heterogeneity of refractory anemia subtype among different countries

Massimo Breccia

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 100 KB

english, 2010

79

Concomitant use of imatinib and warfarin in chronic phase chronic myeloid leukemia patients does not interfere with drug efficacy

Massimo Breccia, Michelina Santopietro, Giuseppina Loglisci, Fabio Stagno, Laura Cannella, Ida Carmosino, Giuliana Alimena

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 105 KB

english, 2010

80

Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients

Massimo Breccia, Vincenzo Federico, Roberto Latagliata, Caterina Mercanti, Gianna Maria D’Elia, Laura Cannella, Giuseppina Loglisci, Adriano Salaroli, Michelina Santopietro, Giuliana Alimena

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 287 KB

english, 2011

81

Efficacy of bendamustine as salvage treatment in an heavily pre-treated Hodgkin lymphoma

Gianna Maria D’Elia, Federico De Angelis, Massimo Breccia, Giorgia Annechini, Sara Panfilio, Roberta Danieli, Elena Cavalieri, Alessandro Pulsoni

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 166 KB

english, 2010

82

“Real-life” results of front-line treatment with Imatinib in older patients (≥65 years) with newly diagnosed chronic myelogenous leukemia

Roberto Latagliata, Massimo Breccia, Ida Carmosino, Laura Cannella, Rosa De Cuia, Daniela Diverio, Anna Frustaci, Giuseppina Loglisci, Marco Mancini, Michelina Santopietro, Caterina Stefanizzi, Paola

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 212 KB

english, 2010

83

Erythroid response and decrease of WT1 expression after proteasome inhibition by bortezomib in myelodysplastic syndromes

Giuliana Alimena, Massimo Breccia, Pellegrino Musto, Daniela Cilloni, Fiorella D’Auria, Roberto Latagliata, Grazia Sanpaolo, Enrico Gottardi, Giuseppe Saglio, Franco Mandelli

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 237 KB

english, 2011

84

Is imatinib-related cardiotoxicity still an open issue?

Massimo Breccia

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 97 KB

english, 2011

85

Sudden acute leukemia transformation in a MDS patient with del(5q) in complete cytogenetic remission after lenalidomide

Massimo Breccia, Laura Cannella, Roberto Latagliata, Mauro Nanni, Michelina Santopietro, Giuseppina Loglisci, Antonietta Ferretti, Rita Barzotti, Esther N. Oliva, Giuliana Alimena

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 214 KB

english, 2011

86

Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib

Massimo Breccia, Michelina Santopietro, Laura Cannella, Vincenzo Federico, Giuseppina Loglisci, Alessandra Serrao, Luigi Petrucci, Adriano Salaroli, Mauro Nanni, Maria Stefania De Propris, Daniela Div

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 101 KB

english, 2011

87

Test of 2000 phototubes for the CDF endplug calorimeter upgrade

L. Breccia, S.W. Delchamps, I. Fiori, G. Farinelli, J. Freeman, T. Jaffrey, W. Kinney, W. Koska, P. Limon, M. Mishina, G. Pauletta, J. Strait, S. Zucchelli

Journal:

Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment

Year:

2004

Language:

english

File:

PDF, 3.87 MB

english, 2004

88

Radiochemical and electrochemical studies of the interaction of Zn2+(65ZN) with the radiosensitizer misonidazole

E. Gattavecchia, D. Tonelli, A. Breccia, E. Ferri

Journal:

Inorganica Chimica Acta

Year:

1988

Language:

english

File:

PDF, 449 KB

english, 1988

89

On the biosynthesis of the terpene marrubiin from [1,4-14C]succinic acid and [2-14C] mevalolactone.

Ada Abbondanza, Roberto Badiello, Alberto Breccia

Journal:

Tetrahedron Letters

Year:

1965

Language:

english

File:

PDF, 219 KB

english, 1965

90

The search for a peptide ligand targeting the lipolytic enzyme cutinase

Javier D Breccia, Margareta Krook, Mats Ohlin, Rajni Hatti-Kaul

Journal:

Enzyme and Microbial Technology

Year:

2003

Language:

english

File:

PDF, 125 KB

english, 2003

91

Purification and characterization of a thermostable xylanase from Bacillus amyloliquefaciens

Javier D. Breccia, Faustino Siñeriz, Mario D. Baigorí, Guillermo R. Castro, Rajni Hatti-Kaul

Journal:

Enzyme and Microbial Technology

Year:

1998

Language:

english

File:

PDF, 1.02 MB

english, 1998

92

P015 Clinical and prognostic features of patients with myelodysplastic/myeloproliferative syndrome categorised as unclassified (MDS/MPD-U) by WHO classification

M. Breccia, F. Gentilini, C. Stefanizzi, A. Levi, F. Natalino, R. Latagliata, M. Nanni, G. Alimena

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 64 KB

english, 2007

93

P100 Retrospective WHO re-classification of 650 MDS patients diagnosed by FAB criteria: prognostic relevance

M. Breccia, F. Gentilini, C. Stefanizzi, F. Natalino, R. Latagliata, A. Levi, G. Alimena

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 55 KB

english, 2007

94

P125 Pregnancy in patients with myelodysplastic syndromes (MDS)

P. Volpicelli, R. Latagliata, M. Breccia, I. Carmosino, C. Stefanizzi, E. Iannella, A. Levi, F. Natalino, G. Alimena

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 54 KB

english, 2007

95

P142 Darbepoetin for the treatment of anemia of myelodysplastic syndromes: efficacy and quality of life

E.N. Oliva, R. Latagliata, M. Danova, G. Specchia, S. Impera, B. Rovati, I. Vincelli, V. Liso, G. Alimena, F. Ronco, I. Carmosino, A. Risitano, M. Breccia, F. Nobile

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 72 KB

english, 2007

96

P017 WPSS versus Simplified Myelodysplastic Syndrome Risk Score: which is the best tool for prediction of survival in myelodysplastic patients?

M. Breccia, R. Latagliata, L. Cannella, F. Gioiosa, A. Fama, C. Stefanizzi, F. Vincenzo, C. Mercanti, M. Santopietro, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 38 KB

english, 2009

97

P001 Prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal

M. Breccia, R. Latagliata, V. Federico, C. Mercanti, L. Cannella, F. Gioiosa, A. Fama, C. Stefanizzi, M. Santopietro, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 45 KB

english, 2009

98

P016 Revised WHO 2008 classification of patients with RCUD (refractory cytopenia with unilineage dysplasia)

M. Breccia, R. Latagliata, L. Cannella, F. Gioiosa, A. Fama, C. Stefanizzi, F. Vincenzo, C. Mercanti, M. Santopietro, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 38 KB

english, 2009

99

P066 Familiar occurrence of myelodysplastic sydrome with del(5q)

L. Napoleone, R. Latagliata, M. Breccia, F. Vozella, I. Carmosino, R. De Cuia, M. Mancini, P. Volpicelli, C. Stefanizzi, L. Cannella, C. Mercanti, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 58 KB

english, 2009

100

P106 High-dose rHuEPO for the treatment of patients with low-risk myelodysplastic syndromes

R. Latagliata, E. Oliva, P. Volpicelli, L. Napoleone, I. Carmosino, M. Breccia, C. Stefanizzi, I. Vincelli, C. Alati, F. Vozella, F. Nobile, G. Alimena

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 43 KB

english, 2009

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски